General plan guidance

It applies when FDA orders postmarket surveillance under section 522 of the FD&C Act. Device-specific guidance may add to it for a particular device.

General plan guidance means agency guidance that provides information about the requirement to conduct postmarket surveillance, the submission of a plan to us for approval, the content of the submission, and the conduct and reporting requirements of the surveillance.

21 CFR, 822.3